Skip to content
All news
Earnings

Texas Instruments (TXN) Beats Q1 Estimates, Raises Q2 Outlook; Stock Up 7.5%

Texas Instruments (TXN) reported Q1 2026 results that beat analyst expectations, with revenue of $4.825 billion and net income of $1.545 billion. The company also raised its Q2 guidance to $5.0-5.4 billion, citing strong demand in data centers, industrial, and AI markets. The stock jumped 7.5% following the announcement.

May 7, 2026
2 min read
Source: Simply Wall St.
Share:

Key Numbers

revenue
4.825B
net income
1.545B
eps
1.77-2.05
q2 revenue guidance
5.0B-5.4B

Texas Instruments (TXN) reported first-quarter 2026 results that surpassed analyst estimates, posting revenue of $4.825 billion and net income of $1.545 billion. The stock rose 7.5% after the company also issued an upbeat second-quarter outlook.

Key Financial Results

MetricQ1 2026
Revenue$4.825 billion
Net Income$1.545 billion
EPS (guidance)$1.77 - $2.05

Year-over-year comparisons were not provided.

Highlights from the Release

The company attributed the strong performance to increased demand in data centers, industrial, and AI-related markets. It also noted that ongoing manufacturing investments are positioning it to meet this demand.

Future Guidance

For Q2 2026, Texas Instruments expects revenue between $5.0 billion and $5.4 billion, with EPS in the range of $1.77 to $2.05, both above consensus estimates.

Stock Impact

Shares of TXN surged 7.5% in after-hours trading, reflecting investor optimism over the beat and raised guidance.

What This Means for Investors

Texas Instruments' results highlight robust demand in key growth areas like AI and data centers, reinforcing its competitive position in the semiconductor industry. However, investors should monitor overall demand trends and geopolitical risks that could impact the sector.

Frequently Asked Questions

Revenue was $4.825 billion.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.